ARE N-of-1 trials an economically viable option to improve access to selected high cost medications? The Australian experience

Value in Health

Volumn 11, Issue 1, 2008, Pages 97-109

  Scuffham, Paul A ^a   Yelland, Michael J ^a   Nikles, Jane ^b   Pietrzak, Eva ^b   Wilkinson, David ^b  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Celecoxib; Chronic neuropathic pain; Cost effectiveness; Gabapentin; N of 1 trials; Osteoarthritis

Indexed keywords

CELECOXIB; GABAPENTIN; PARACETAMOL; PLACEBO;

ARTICLE; AUSTRALIA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; ECONOMIC ASPECT; GENERAL PRACTICE; HEALTH CARE ACCESS; HUMAN; NEUROPATHIC PAIN; OSTEOARTHRITIS; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SUSTAINED DRUG RELEASE; TREATMENT RESPONSE;

EID: 38549098970     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2007.00218.x     Document Type: Article

References (20)

1. Summary of PBS processing year ending 30 June 2004. In : Health Insurance Commission Pharmaceutical Benefits Schedule Item Statistics, December 22, 2004. Available from: http://www.hic.gov.au/statistics/dyn_pbs/forms/pbs_tab1.shtml [accessed January 20, 2005].
2. Cameron HJ, Williams BO. Clinical trials in the elderly. Should we do more? Drugs Aging 1996 9 : 307 10.
3. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?" Lancet 2005 365 : 82 93.
4. Larson EB, Ellsworth AJ. An evidence based approach to individualising treatment. JAMA 1993 70 : 2708 12.
5. Guyatt GH, Haynes RB, Jaeschke RZ, et al. Users' Guides to the Medical Literature. XXV. Evidence-based medicine: principles for applying the Users' Guides to patient care. Evidence-Based Med Working Group. JAMA 2000 284 : 1290 6.
6. Karnon J, Qizilbash N. Economic evaluation alongside N-of-1 trials: getting closer to the margin. Health Econ 2001 10 : 79 82.
7. Guyatt GH, Keller JL, Jaeschke R, et al. The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med 1990 112 : 293 9.
8. Pope JE, Prashker M, Anderson J. The efficacy and cost effectiveness of N-of-1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis. J Rheumatol 2004 31 : 140 9.
9. Ehrich EW, Davies GM, Watson DJ, et al. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol 2000 27 : 2635 41.
10. Zisapel N, Nir T. Determination of the minimal clinically significant difference on a patient visual analog sleep quality scale. J Sleep Res 2003 12 : 291 8.
11. Chatman AB, Hyams SP, Neel JM, et al. The Patient-Specific Functional Scale: measurement properties in patients with knee dysfunction. Phys Ther 1997 77 : 820 9.
12. Yelland MJ, Nikles CJ, McNairn N, et al. Celecoxib compared to sustained-release paracetamol for osteoarthritis: a series of n-of-1 trials. Rheumatology (Oxford) 2007 46 : 135 40.
13. Yelland MJ, Nikles CJ, McNairn N, et al. Single patient trials of gabapentin for chronic neuropathic pain. In: Abstracts, 11th World Congress on Pain, Sydney, Australia, 2005. Seattle : IASP Press, p. 221.
14. TreeAge Pro 2006 Suite [computer program] Version Release 1. Williamstown, MA : TreeAge Software, 2006.
15. Australian Institute of Health and Welfare (AIHW). Grim (General Record of Incidence of Mortality) Books. Canberra : AIHW, 2005.
16. Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population survey. Health Econ 1996 5 : 141 54.
17. Commonwealth Department of Health and Ageing. Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee. Canberra : Publications Production Unit, 2002.
18. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005 353 : 487 97.
19. Donohoo E (Ed). MIMS Annual 2005. Sydney Australia : CMP Medica, 2005.
20. World Medical Organization. Declaration of Helsinki. Br Med J 1996 313 (7070) : 1448 9.